top of page

Spectra DIAGNOSTIC

Updated: Nov 22, 2022


THE FRANCOPHONE JOURNAL OF MEDICAL DIAGNOSTIC

n18 . December 2021- January - February 2022


HYCOR Biomedical is recognized as a leading diagnostic solution provider to watch in 2022.

Download your copy (French only)


Routine IgE testing with only 4 μL of sample

HYCOR Biomedical, manufacturer and global distributor of solutions for in vitro diagnostics, in particular offers the NOVEOS immunoassay analyzer, intended to medium to high volume labs.


This system was developed to meet the challenges faced by laboratories during routine specific IgE testing. This innovation combines approved technologies to innovative methods that make it possible to obtain quality results and reduce operating costs thanks to to better efficiency.


Thanks to numerous contributions from laboratories and clinicians around the world, allergy-focused design offers significant competitive advantages. The system requires only 4 μL of sample per test, which reduces under-quantity errors, resampling and patient trauma. Cutting-edge technology

microparticles limits interference from: Biotin, IgG/IgG4 and solid phase-linked carbohydrate determinants (CCD). Small sample volume per test results in less interference with serum-based substances. The approach with microparticles allows a frank increase of the surface leading to a very good sensitivity, a excellent accuracy in low values and offers up to 13 hours of battery life for lab technicians.


This highly automated instrument with full operational capability works with ready-to-use liquid reagents allowing much larger batch sizes.





HYCOR Europe B.V. – 5 rue de Castiglione – 75001 ParisT l. : +33 (0)1 30 46 75 21




bottom of page